日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

干扰素-α鼻喷雾剂预防可降低癌症患者的COVID-19感染率:一项随机、双盲、安慰剂对照试验。

Yong Michelle K, Thursky Karin, Crane Megan, Spelman Tim, Mahar Robert K, Simpson Julie A, Scott Andrew M, Harrison Simon J, Szer Jeff, Pellegrini Marc, Lingaratnam Senthil, Pang Ken C, Tennakoon Surekha, Sim Beatrice Z, Blyth Emily, Gan Hui K, Quach Hang, McIntosh Michelle P, Page Hayley, Woolstencroft Rachel, Slavin Monica

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy

接受抗逆转录病毒治疗的HIV-HBV合并感染患者肝病进展的预测因素

Singh, Kasha P; Avihingsanon, Anchalee; Zerbato, Jennifer M; Zhao, Wei; Braat, Sabine; Tennakoon, Surekha; Rhodes, Ajantha; Matthews, Gail V; Fairley, Christopher K; Sasadeusz, Joe; Crane, Megan; Audsley, Jennifer; Lewin, Sharon R

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.

接受抗逆转录病毒治疗的 HIV-乙型肝炎合并感染患者的肝细胞中仍然存在 HIV DNA

Zerbato Jennifer M, Avihingsanon Anchalee, Singh Kasha P, Zhao Wei, Deleage Claire, Rosen Elias, Cottrell Mackenzie L, Rhodes Ajantha, Dantanarayana Ashanti, Tumpach Carolin, Tennakoon Surekha, Crane Megan, Price David J, Braat Sabine, Mason Hugh, Roche Michael, Kashuba Angela D M, Revill Peter A, Audsley Jennifer, Lewin Sharon R

Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy

对接受泽布替尼治疗的患者接种 COVID-19 疫苗后的免疫反应进行前瞻性全面分析

Nguyen, Thi H O; Lim, Chhay; Lasica, Masa; Whitechurch, Ashley; Tennakoon, Surekha; Saunders, Natalie R; Allen, Lilith F; Rowntree, Louise C; Chua, Brendon Y; Kedzierski, Lukasz; Tan, Hyon-Xhi; Wheatley, Adam K; Kent, Stephen J; Karapanagiotidis, Theo; Nicholson, Suellen; Williamson, Deborah A; Slavin, Monica A; Tam, Constantine S; Kedzierska, Katherine; Teh, Benjamin W

Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study

抗PD-1和抗CTLA-4对接受抗逆转录病毒治疗的HIV合并癌症患者体内人类免疫缺陷病毒(HIV)库的影响:艾滋病恶性肿瘤联盟095研究

Rasmussen, Thomas A; Rajdev, Lakshmi; Rhodes, Ajantha; Dantanarayana, Ashanti; Tennakoon, Surekha; Chea, Socheata; Spelman, Tim; Lensing, Shelly; Rutishauser, Rachel; Bakkour, Sonia; Busch, Michael; Siliciano, Janet D; Siliciano, Robert F; Einstein, Mark H; Dittmer, Dirk P; Chiao, Elizabeth; Deeks, Steven G; Durand, Christine; Lewin, Sharon R

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.

一项关于在急性 HIV-1 感染期间开始抗逆转录病毒治疗后中断治疗的伏立诺他随机试验

Kroon Eugène D M B, Ananworanich Jintanat, Pagliuzza Amélie, Rhodes Ajantha, Phanuphak Nittaya, Trautmann Lydie, Mitchell Julie L, Chintanaphol Michelle, Intasan Jintana, Pinyakorn Suteeraporn, Benjapornpong Khuntalee, Chang J Judy, Colby Donn J, Chomchey Nitiya, Fletcher James L K, Eubanks Keith, Yang Hua, Kapson John, Dantanarayana Ashanti, Tennakoon Surekha, Gorelick Robert J, Maldarelli Frank, Robb Merlin L, Kim Jerome H, Spudich Serena, Chomont Nicolas, Phanuphak Praphan, Lewin Sharon R, de Souza Mark S